Search research articles
Contact Us
Filters
Showing results (201-210 of 207) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 207 results.
Journal of Thrombosis and Haemostasis : JTH
|
October 21, 2019
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D McBane, Waldemar E Wysokinski, Jennifer G Le-Rademacher, et al.
Vascular Medicine (London, England)
|
May 10, 2022
Artificial intelligence for the evaluation of peripheral artery disease using arterial Doppler waveforms to predict abnormal ankle-brachial index
Robert D McBane, Dennis H Murphree, David Liedl, et al.
Mayo Clinic Proceedings
|
June 26, 2021
Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis
Irbaz Bin Riaz, Harry E Fuentes, Syed Arsalan Ahmed Naqvi, et al.
Mayo Clinic Proceedings
|
February 10, 2019
Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
Dalene M Bott-Kitslaar, Robert D McBane, Ana I Casanegra, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 27, 2024
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial
Robert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 21, 2024
Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714]
Robert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Mayo Clinic Proceedings
|
November 6, 2020
Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic
Robert D McBane, Victor D Torres Roldan, Alexander S Niven, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 207) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 207 results.
Journal of Thrombosis and Haemostasis : JTH
|
October 21, 2019
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D McBane, Waldemar E Wysokinski, Jennifer G Le-Rademacher, et al.
Vascular Medicine (London, England)
|
May 10, 2022
Artificial intelligence for the evaluation of peripheral artery disease using arterial Doppler waveforms to predict abnormal ankle-brachial index
Robert D McBane, Dennis H Murphree, David Liedl, et al.
Mayo Clinic Proceedings
|
June 26, 2021
Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis
Irbaz Bin Riaz, Harry E Fuentes, Syed Arsalan Ahmed Naqvi, et al.
Mayo Clinic Proceedings
|
February 10, 2019
Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
Dalene M Bott-Kitslaar, Robert D McBane, Ana I Casanegra, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 27, 2024
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial
Robert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 21, 2024
Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714]
Robert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Mayo Clinic Proceedings
|
November 6, 2020
Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic
Robert D McBane, Victor D Torres Roldan, Alexander S Niven, et al.
Page
of 21